Pallidal Stimulation and Gilles de la Tourette Syndrome (STIC)
Primary Purpose
Gilles de la Tourette Syndrome
Status
Completed
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
Deep brain stimulation
Sponsored by
About this trial
This is an interventional treatment trial for Gilles de la Tourette Syndrome focused on measuring Gilles de la Tourette syndrome, Deep brain stimulation, Globus PALLIDUS
Eligibility Criteria
Inclusion Criteria:
- Severe form of GTS
- age 18 to 60 years
- failure of medical treatment (including neuroleptics)
Exclusion Criteria:
- Major depression
- Psychotic symptoms
- Severe personality disorder
Sites / Locations
- Groupe hospitalier la Pitié Salpétrière
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
1
Arm Description
Deep brain stimulation
Outcomes
Primary Outcome Measures
To evaluate the therapeutic effect of the high frequency bilateral stimulation of GPI in severe forms and invalidating MGT, in a protocol randomized as a double blind man in parallel groups.
The assumption tested is that of the frank improvement (> 60% on scale YGTSS) of the symptoms of the MGT by the bilateral stimulation of GPI in its former part.
Secondary Outcome Measures
To evaluate time necessary to obtaining the maximum effect and its evolution after this one (maintenance or not of the effect in the course of time)
To study the effects of the stimulation of GPI in its former part, on the driving tics simple and complex, vocal, the self-mutilations, and the psychopathology of which time, emotions and impulsiveness
To evaluate the repercussion of this technique on the sociological-professional handicap, operation and the adaptation
To seek determinants before intervention of the effectiveness of stimulation (determining neurological, psychiatric, neuropsychological, functional)
To establish correlations between the localization of the studs of stimulation (retiming atlas/IRM) and the symptoms
To determine the modifications of cerebral activation induced by the bilateral stimulation of GPI at the time of the improvement of the neurological symptoms (study in Mtoe).
Full Information
NCT ID
NCT00478842
First Posted
May 24, 2007
Last Updated
February 20, 2017
Sponsor
Assistance Publique - Hôpitaux de Paris
1. Study Identification
Unique Protocol Identification Number
NCT00478842
Brief Title
Pallidal Stimulation and Gilles de la Tourette Syndrome
Acronym
STIC
Official Title
Treatment of Gilles de la Tourette Syndrome by Bilateral Stimulation of the Internal Part of the Globus PALLIDUS
Study Type
Interventional
2. Study Status
Record Verification Date
February 2017
Overall Recruitment Status
Completed
Study Start Date
November 2007 (undefined)
Primary Completion Date
December 2016 (Actual)
Study Completion Date
December 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The aim of this study is to evaluate the efficacy and safety of bilateral pallidal stimulation in patients with a severe form of Gilles de la Tourette syndrome.
Detailed Description
It acts of a randomized study, in parallel, double group blind, multi-centric relating to 14 patients.
The interest of this multicentric study, which will be carried out in centers specialized in the field of major cerebral stimulation with for each one a multidisciplinary team, is to carry out a homogeneous protocol which should make it possible to give a clear response in term of effectiveness for this treatment in this pathology.
The evaluation will be:
neurological (YGTSS, video scale of the tics);
psychiatric, with in particular of the specific psychopathological evaluations centered on mood;
neuropsychological, centered on impulsiveness;
functional calculus evaluating total operation and the social adaptation;
neurophysiological (recording of the neuronal activities).
Calculations of the number of subjects necessary showed, by laying down the principal objective at an improvement of at least 60 % of the score of the YGTSS under treatment, which 14 subjects will make it possible to show a significant difference with the procedure placebo.
Study in Tomography by Emission of Positrons (Mtoe) carried out on 8 of the 14 operated patients having had at least 3 months of stimulation, in comparison on 8 pilot subjects (paired for the sex and the age), should make it possible to determine, at the time of the improvement of the driving symptoms, modifications of cerebral activation induced by the high frequency stimulation of GPI among patients.
The association of this study to the comparison of the improvement of the neurological symptoms with the precise localization of the therapeutic stud of the electrode reformatted on the post-operative TDM (8), carried out for all the patients, should make it possible to specify the anatomy-physiological bases to specify the anatomy-physiological bases of the MGT The duration of the study will be 14 month for each patient, that is to say one 2 months preoperative period intended for inclusion; one 3 months post-operative period without stimulation; one period randomized with stimulation either "one" (3 months), or "off" (3 months), then an open study for all the patients with stimulation "one" for one 6 months duration.
It is envisaged to include 14 patients reached of the MGT (of which 8 will take part in study Mtoe) and 8 subjects controls for study Mtoe is 22 subjects.
An observational follow-up at 30 and 48 months is added.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gilles de la Tourette Syndrome
Keywords
Gilles de la Tourette syndrome, Deep brain stimulation, Globus PALLIDUS
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Description
Deep brain stimulation
Intervention Type
Device
Intervention Name(s)
Deep brain stimulation
Intervention Description
Deep brain stimulation
Primary Outcome Measure Information:
Title
To evaluate the therapeutic effect of the high frequency bilateral stimulation of GPI in severe forms and invalidating MGT, in a protocol randomized as a double blind man in parallel groups.
Time Frame
during the 44 months
Title
The assumption tested is that of the frank improvement (> 60% on scale YGTSS) of the symptoms of the MGT by the bilateral stimulation of GPI in its former part.
Time Frame
at the end of 44 months
Secondary Outcome Measure Information:
Title
To evaluate time necessary to obtaining the maximum effect and its evolution after this one (maintenance or not of the effect in the course of time)
Time Frame
during the study
Title
To study the effects of the stimulation of GPI in its former part, on the driving tics simple and complex, vocal, the self-mutilations, and the psychopathology of which time, emotions and impulsiveness
Time Frame
during the 44 months
Title
To evaluate the repercussion of this technique on the sociological-professional handicap, operation and the adaptation
Time Frame
during the 44 months
Title
To seek determinants before intervention of the effectiveness of stimulation (determining neurological, psychiatric, neuropsychological, functional)
Time Frame
during the 44 months
Title
To establish correlations between the localization of the studs of stimulation (retiming atlas/IRM) and the symptoms
Time Frame
during the 44 months
Title
To determine the modifications of cerebral activation induced by the bilateral stimulation of GPI at the time of the improvement of the neurological symptoms (study in Mtoe).
Time Frame
during the 44 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Severe form of GTS
age 18 to 60 years
failure of medical treatment (including neuroleptics)
Exclusion Criteria:
Major depression
Psychotic symptoms
Severe personality disorder
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marie-Laure WELTER, MD,PhD
Organizational Affiliation
Assistance Publique - Hôpitaux de Paris
Official's Role
Principal Investigator
Facility Information:
Facility Name
Groupe hospitalier la Pitié Salpétrière
City
Paris
ZIP/Postal Code
75013
Country
France
12. IPD Sharing Statement
Citations:
PubMed Identifier
15965209
Citation
Houeto JL, Karachi C, Mallet L, Pillon B, Yelnik J, Mesnage V, Welter ML, Navarro S, Pelissolo A, Damier P, Pidoux B, Dormont D, Cornu P, Agid Y. Tourette's syndrome and deep brain stimulation. J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):992-5. doi: 10.1136/jnnp.2004.043273.
Results Reference
result
PubMed Identifier
28645853
Citation
Welter ML, Houeto JL, Thobois S, Bataille B, Guenot M, Worbe Y, Hartmann A, Czernecki V, Bardinet E, Yelnik J, du Montcel ST, Agid Y, Vidailhet M, Cornu P, Tanguy A, Ansquer S, Jaafari N, Poulet E, Serra G, Burbaud P, Cuny E, Aouizerate B, Pollak P, Chabardes S, Polosan M, Borg M, Fontaine D, Giordana B, Raoul S, Rouaud T, Sauvaget A, Jalenques I, Karachi C, Mallet L; STIC study group. Anterior pallidal deep brain stimulation for Tourette's syndrome: a randomised, double-blind, controlled trial. Lancet Neurol. 2017 Aug;16(8):610-619. doi: 10.1016/S1474-4422(17)30160-6. Epub 2017 Jun 20.
Results Reference
derived
Learn more about this trial
Pallidal Stimulation and Gilles de la Tourette Syndrome
We'll reach out to this number within 24 hrs